Impact of part D low-income subsidies on medication patterns for medicare beneficiaries with diabetes

Medical Care

Volumn 50, Issue 11, 2012, Pages 913-919

  Stuart, Bruce ^a   Yin, Xianghua ^b   Davidoff, Amy ^a   Simoni Wastila, Linda ^a   Zuckerman, Ilene ^a   Shoemaker, J Samantha ^a   Doshi, Jalpa ^c  

^a INTER AMERICAN DEVELOPMENT BANK   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

drug utilization; low income subsidy; Medicare Part D

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; RENIN INHIBITOR;

AGED; ARTICLE; COMORBIDITY; DIABETES MELLITUS; DRUG EXPOSURE; DRUG UTILIZATION; FEMALE; FINANCIAL MANAGEMENT; HUMAN; LOW INCOME SUBSIDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHOLESTEROL, LDL; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; POVERTY; PUBLIC ASSISTANCE; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84867736298     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31826c85f9     Document Type: Article

References (27)

1. Kaiser Family Foundation. Low-Income Assistance under the Medicare Drug Benefit. Publication 7327-05. Washington, DC: Kaiser Family Foundation; 2009.
2. Basu A, Yin W, Alexander G. Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. Health Serv Res. 2010;45:133-151.
3. Shrank WH, Patrick A, Pedan A, et al. The effect of transitioning to Medicare Part D drug coverage in seniors dually eligible for Medicare and Medicaid. JAGS. 2008;56:2304-2310.
4. Donohue JM, Frank RG. Estimating Medicare Part D's impact on medication access among dully eligible beneficiaries with mental disorders. Psychiatr Serv. 2007;58:1285-1291. (Pubitemid 350043578)
5. Medicare Payment Advisory Commission. Report to Congress on Medicare Payment Policy. Washington, DC: MedPAC; 2010.
6. Centers for Medicare and Medicaid Services. Medicare and You 2010. Washington, DC: CMS; 2010.
7. Davidoff A, Stuart B, Shaffer T, et al. Lessons learned: who didn't enroll in Medicare drug coverage, and why? Health Aff. 2010;29:1255-1263.
8. Rudolph NV, Montgomery MA. Low-income Medicare beneficiaries and their experiences with the Part D prescription drug benefit. Inquiry. 2010;47:162-172.
9. Balkrishnan R, Rajagopalan R, Camacho FT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958-2971. (Pubitemid 37510603)
10. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diab Educ. 2007;33:1014-1029; discussion 1030-1031.
11. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: WHO; 2003.
12. Lundberg L, Johannesson M, Isacson DG, et al. Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy. 1998;44:123-134. (Pubitemid 28275957)
13. Lillard LA, Rogowski J, Kingston R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med Care. 1999;37:926-936.
14. Schneeweiss S, Patrick AR, Pedan A, et al. The effects of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff. 2009;28:w305-w316.
15. Barron J, Wahl P, Fisher M, et al. Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications. Pharm Ther. 2008;33:532-541.
16. Hunt J, Rozenfeld Y, Shenolikar R. Effect of patient medication cost share on adherence and glycemic control. Manag Care. 2009;47-53.
17. Buccaneer. Chronic Condition Warehouse User Manual, Version 1.5, May 2009. Available at: http://www.ccwdata.org/cs/groups/public/documents/document/ ccw-userguide.pdf. Accessed November 2010.
18. American Diabetes Association. Standards of medical care in diabetes. Diab Care. 2008;31(suppl 1):S12-S54.
19. Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society panel on improving care for elders with diabetes: guidelines for improving the care of the older person with diabetes mellitus. JAGS. 2003;51:S265-S280.
20. RTI International Spatial Impact Factor Database. October 1, 2009. Available at: http://www.ccwdata.org/cs/groups/public/documents/document/ccw- userguide.pdf. Accessed November 15, 2010.
21. Pope G, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004;25:119-141. (Pubitemid 39201560)
22. Medical Economics. Red Book: Pharmacy's Fundamental Reference, 2009 Edition. New York: Medical Economics Company; 2009.
23. Stuart B, Lloyd J, Simoni-Wastila L, et al. Increased persistency in Medication use by US Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diab Care. 2009;32:647-649.
24. Rosen A. Indications for and utilization of ACE inhibitors in older individuals with diabetes. JGIM. 2006;21:315-319.
25. Mingfang L, Ong KL, Tse HF, et al. Utilization of lipid lowering medications among adults in the United States. Atherosclerosis. 2010;208:456-460.
26. Cramer JA. A systematic review of adherence with medications for diabetes. Diab Care. 2004;27:1218-1224. (Pubitemid 38579798)
27. Salas M, Hughes D, Zuluaga A, et al. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health. 2009;12:915-922.